Fundraising Fox

Aaron Kantoff

Investor

Managing Partner at Scion Life Sciences Β· Board director at Rayze Bio

New York, New York, United States

About

Aaron Kantoff is a founder and Managing Partner of Scion, with about 15 years spent founding, building, and investing in life sciences companies focused on therapeutics. He was previously a Venture Partner at Medicxi and a Partner at Apple Tree Partners, where he helped launch several portfolio companies and worked on crossover and public biotech investments. He holds a B.S. in Finance and International Business from NYU's Stern School of Business.

ContactΒ· self-published, not guessed

Invests in

Biotech

Board director at Rayze Bio

Intro paths

β†’

In turn, Aaron can intro founders to Rayze Bio's investors below.

Co-founders at Rayze Bio

KS
Ken SongExecutive Officer, Director

Experience

  1. Scion Life SciencesCo-Founder & Managing Partnercurrent2022 β€” presentNew York
  2. Avalo TherapeuticsBoard Membercurrent2024 β€” presentWayne, Pennsylvania, United States
  3. The Lustgarten FoundationBoard Membercurrent2024 β€” presentNew York City Metropolitan Area
  4. Tourmaline BioBoard Member2022 β€” 2025New York
  5. RayzeBioFounding Board Member2020 β€” 2024San Diego, California, United States
  6. Centessa PharmaceuticalsBoard Member2020 β€” 2022Cambridge, Massachusetts & London, UK
  7. medicxiVenture Partner2020 β€” 2021
  8. Akero TherapeuticsBoard Member2017 β€” 2019San Francisco Bay Area
  9. Corvidia TherapeuticsBoard Member2016 β€” 2019Greater Boston Area
  10. Elstar Therapeutics Inc. (now Marengo Therapeutics)Board Member2015 β€” 2019Cambridge, MA
  11. Apple Tree PartnersPartner2011 β€” 2019Greater New York City Area
  12. Limelight Bio (now Ascidian)Board Member2016 β€” 2019Greater Philadelphia Area
  13. SyntimmuneBoard Member2014 β€” 2018Greater Boston Area
  14. Braeburn Pharmaceuticals, Inc.Executive Director, Business Development and Corporate Strategy2012 β€” 2014Princeton, New Jersey

Skills & more

Venture Capital32Financial Modeling27Corporate Development21Business Development13Business Strategy11Biotechnology14Entrepreneurship11Financial Analysis12Investments10Alternative Investments8Portfolio Management9Valuation11
+1 morePharmaceutical Industry

From Aaron's professional profile.

Investments

Board seats

AkeroAscidianAvalo TherapeuticsCentessa Pharmaceuticals PLCCorvidia TherapeuticsMarengoRayze BioStoke TherapeuticsSyntimmuneTourmaline Bio

Per the firm's website.

Colleagues at Scion Life Sciences

Frequently asked questions

Who is Aaron Kantoff?
Aaron Kantoff is a founder and Managing Partner of Scion, with about 15 years spent founding, building, and investing in life sciences companies focused on therapeutics. He was previously a Venture Partner at Medicxi and a Partner at Apple Tree Partners, where he helped launch several portfolio companies and worked on crossover and public biotech investments. He holds a B.S. in Finance and International Business from NYU's Stern School of Business.
Where does Aaron Kantoff work?
Aaron Kantoff is Managing Partner at Scion Life Sciences and Board director at Rayze Bio.
What does Aaron Kantoff invest in?
Aaron Kantoff invests in Biotech.
What boards does Aaron Kantoff sit on?
Aaron Kantoff holds tracked board seats at Akero, Ascidian, Avalo Therapeutics, Centessa Pharmaceuticals PLC, Corvidia Therapeutics, Marengo, Rayze Bio, Stoke Therapeutics, Syntimmune, Tourmaline Bio.
Where did Aaron Kantoff go to school?
Aaron Kantoff studied at New York University - Leonard N. Stern School of Business (B.S., Finance and International Business).

Same school

Shared employers